abbrevi
ccchemokin
ligand
cm
condit
medium
er
estrogen
receptor
monocyt
chemoattract
protein
mr
tumorassoci
macrophag
tamoxifenresist
tumor
microenviron
ms
tumorassoci
macrophag
tamoxifensensit
tumor
microenviron
pf
progressionfre
surviv
tam
tumorassoci
macrophag
tme
tumor
microenviron
breast
cancer
preval
malign
among
women
although
endocrin
therapi
effect
develop
endocrin
resist
major
clinic
challeng
tumor
microenviron
tme
promot
tumor
malign
tumorassoci
macrophag
tam
within
tme
play
crucial
role
endocrin
resist
herein
aim
elucid
relationship
tam
endocrineresist
phenotyp
breast
cancer
macrophag
cultur
condit
medium
cm
tamoxifensensit
resist
breast
cancer
cell
polar
detect
immunofluoresc
determin
effect
endocrin
resist
cell
cultur
supernat
differ
tam
treat
tamoxifen
ccchemokin
ligand
immunohistochemistri
carri
patholog
section
patient
invas
estrogen
receptorposit
breast
cancer
found
macrophag
cultur
cm
cell
induc
tam
obviou
polar
latter
tamoxifen
resist
increas
cultur
tam
medium
tam
secret
increas
endocrin
resist
breast
cancer
cell
activ
signal
pathway
high
express
correl
infiltr
r
p
patient
high
express
present
shorter
progressionfre
surviv
low
express
p
conclud
secret
tam
activ
signal
promot
endocrin
resist
feedback
loop
tme
suggest
tam
may
novel
therapeut
target
patient
endocrineresist
breast
cancer
breast
cancer
common
caus
cancerrel
mortal
women
approxim
breast
cancer
hormon
receptorposit
although
endocrin
therapi
remain
effect
treatment
efficaci
limit
intrins
acquir
endocrin
resist
tamoxifen
select
er
modul
common
endocrin
therapi
worldwid
henc
resist
tamoxifen
major
clinic
challeng
solid
tumor
breast
cancer
usual
contain
heterogen
popul
neoplast
cell
immun
cell
collect
tissuespecif
resid
recruit
stromal
cell
type
togeth
form
tme
relev
tumor
heterogen
link
variou
hallmark
cancer
includ
drug
resist
macrophag
divers
cell
show
distinct
phenotyp
depend
anatom
locat
activ
stimuli
breast
cancer
macrophag
compris
tme
among
macrophag
commonli
refer
tam
associ
tumor
malign
scaveng
receptor
regard
highli
specif
monocytemacrophag
marker
polar
escamilla
et
al
report
tam
involv
resist
patient
prostat
cancer
androgen
blockad
therapi
previou
studi
found
correl
tam
tamoxifen
resist
patient
breast
cancer
underli
mechan
elucid
tumorassoci
macrophag
secret
varieti
chemokin
tme
includ
secret
mainli
macrophag
cocultur
cell
also
known
small
induc
cytokin
belong
cc
chemokin
famili
recruit
monocyt
memori
cell
dendrit
cell
site
inflamm
sever
studi
report
inflammatori
environ
promot
malign
behavior
differ
tumor
xu
et
al
found
recruit
monocyt
tme
polar
macrophag
type
secret
also
import
manifest
tam
polar
macrophag
ueno
et
al
show
high
level
express
signific
indic
earlier
relaps
howev
studi
role
endocrin
resist
breast
cancer
molecular
mechan
underli
endocrin
resist
breast
cancer
highli
complic
involv
mani
molecul
pathway
overexpress
epiderm
growth
factor
receptor
andor
oncogen
mutat
er
loss
eralpha
express
activ
mapk
signal
pathway
overexpress
cytochrom
enzym
among
factor
activ
signal
pathway
domin
thota
et
al
observ
induct
endocrin
resist
tumor
macrophag
although
intrins
molecular
mechan
remain
unclear
aim
present
studi
explor
interact
tam
endocrineresist
phenotyp
breast
cancer
cm
tamoxifensensit
resist
breast
cancer
cell
test
abil
induc
macrophag
polar
examin
role
tam
promot
tamoxifen
resist
also
identifi
specif
cytokin
secret
tam
promot
endocrin
resist
investig
underli
mechan
action
immunohistochemistri
carri
patholog
section
patient
invas
erposit
breast
cancer
examin
correl
express
diseas
prognosi
find
understand
tam
promot
tamoxifen
resist
breast
cancer
cell
may
identifi
novel
therapeut
target
patient
endocrineresist
breast
cancer
cell
prolifer
assess
use
vazym
assay
accord
manufactur
instruct
briefli
cell
seed
plate
densiti
cellswel
incub
tamoxifen
hour
k
e
w
r
breast
cancer
tamoxifen
resist
tumor
microenviron
tumorassoci
macrophag
end
respect
incub
time
cell
incub
complet
medium
contain
reagent
hour
subsequ
absorb
sampl
measur
nm
micropl
reader
tecan
experi
repeat
three
time
ms
mr
human
macrophag
grown
small
cultur
dish
fix
paraformaldehyd
minut
follow
wash
pb
thrice
cell
block
bsa
minut
incub
antibodi
dilut
overnight
signal
detect
use
alexa
total
rna
extract
ms
mr
macrophag
use
tabl
tumor
necrosi
factor
tnf
present
cultur
supernat
ms
mr
macrophag
quantifi
use
specif
elisa
kit
quantikin
human
immunoassay
quantikin
human
immunoassay
r
system
follow
manufactur
instruct
concentr
sampl
estim
standard
curv
level
detect
limit
assay
record
zero
cell
lyse
ripa
buffer
protein
sampl
sonic
follow
centrifug
g
minut
supernat
collect
protein
concentr
determin
use
bradford
assay
biorad
protein
lysat
subject
trisglycin
sd
page
transfer
onto
pvdf
membran
accord
manufactur
instruct
invitrogen
membran
block
milktrisbuff
salin
tween
tbst
hour
follow
incub
primari
antibodi
overnight
follow
day
membran
wash
tbst
thrice
incub
hrpconjug
secondari
antibodi
cell
signal
hour
protein
express
visual
ecl
chemiluminesc
promega
quantifi
use
imag
j
softwar
nation
cancer
institut
micropor
membran
pore
size
transwel
insert
costar
use
chemotaxi
assay
briefli
cell
ad
upper
chamber
cm
ms
mr
mr
bindarit
ad
lower
chamber
cell
allow
migrat
hour
atmospher
co
air
insert
fix
stain
crystal
stain
solut
nonmigratori
cell
remov
membran
mount
migratori
cell
observ
count
microscop
protocol
studi
approv
ethic
committe
posit
immunoreact
score
stain
intens
neg
weak
moder
strong
stain
percentag
posit
tumor
cell
per
core
tissu
consid
posit
express
stain
intens
cell
examin
yellow
granul
indic
posit
immunoreact
score
infiltr
densiti
macrophag
rang
absent
dens
score
equal
greater
regard
posit
data
express
mean
sd
statist
analys
carri
use
graphpad
prism
softwar
version
spss
statist
softwar
version
multipl
comparison
evalu
use
oneway
anova
correl
determin
use
spearman
rankord
correl
surviv
curv
analyz
use
kaplanmei
method
curv
compar
use
logrank
test
multivari
surviv
analysi
use
cox
regress
proport
hazard
model
carri
adjust
clinic
variabl
may
statist
signific
prognosi
univari
analysi
result
p
valu
consid
statist
signific
p
p
examin
differ
macrophag
cellular
immunofluoresc
flow
cytometri
analysi
carri
ms
mr
consid
polar
maker
tam
found
cm
breast
cancer
cell
line
increas
express
indic
polar
express
higher
polar
signific
mr
ms
figur
c
observ
indic
macrophag
polar
assum
differ
phenotyp
differ
microenviron
figur
thu
conclud
associ
endocrin
resist
promot
tam
two
hormon
receptorposit
cell
line
select
test
effect
confirm
receptor
express
cell
line
figur
nmml
ad
two
cell
line
cell
cultur
hour
subsequ
tamoxifen
ad
four
group
cell
cultur
hour
cell
viabil
assess
use
assay
figur
four
group
also
analyz
flow
cytometri
detect
apoptosi
figur
f
found
promot
endocrin
resist
reduc
apoptot
proport
two
hormon
receptorposit
cell
line
shown
associ
endocrin
resist
cell
line
signal
pathway
classic
pathway
regul
cell
prolifer
apoptosi
endocrin
resist
investig
effect
activ
pathway
cell
treat
nmoll
phosphoryl
akt
mtor
significantli
increas
ad
cm
mr
cell
also
activ
signal
pathway
mr
treat
nmoll
bindarit
synthesi
inhibitor
abil
cm
mr
bindarit
increas
level
phosphoryl
akt
mtor
weaken
figur
result
suggest
tam
promot
endocrin
resist
breast
cancer
cell
partli
secret
activ
mtor
pathway
secret
thought
depend
transcript
factor
activ
tme
test
whether
breast
cancer
cell
macrophag
pro
express
independ
signal
dephosphoryl
transcript
factor
test
activ
pathway
ms
mr
found
activ
pathway
consist
secret
trend
figur
result
suggest
amino
acid
metabol
cm
activ
pathway
tam
promot
secret
wellknown
chemokin
abundantli
present
macrophag
respons
recruit
monocyt
concentr
posit
correl
chemotaxispromot
potenti
alreadi
determin
level
secret
ms
mr
differ
next
question
whether
chemotaxi
cell
induc
three
f
g
u
r
e
ccchemokin
ligand
secret
tumorassoci
macrophag
tam
activ
pathway
induc
endocrin
resist
breast
cancer
cell
rtpcr
show
transcript
seven
cytokin
three
macrophag
tam
tamoxifensensit
tumor
microenviron
tme
ms
tam
tamoxifenresist
tme
mr
chang
trend
consist
previou
experi
result
differ
statist
signific
b
level
condit
medium
cm
tamoxifensensit
breast
cancer
cell
tamoxifenresist
breast
cancer
cell
ms
mr
cell
mainli
produc
macrophag
rather
breast
cancer
cell
c
rel
viabil
nmml
cell
treat
tamoxifen
rel
viabil
nmml
cell
treat
tamoxifen
e
apoptosi
nmml
cell
analyz
flow
cytometri
h
ad
tamoxifen
f
apoptosi
nmml
cell
analyz
flow
cytometri
h
ad
tamoxifen
g
western
blot
analysi
pathway
cm
mr
could
activ
pathway
cell
mr
treat
bindarit
h
activ
pathway
cm
decreas
p
p
p
f
g
u
r
e
tamoxifensensit
breast
cancer
cell
tamoxifenresist
breast
cancer
cell
secret
tumor
necrosi
factor
tnf
induc
activ
nuclear
factor
kappa
b
pathway
tumorassoci
macrophag
tam
level
condit
medium
cm
tam
tamoxifensensit
tumor
microenviron
tme
ms
tam
tamoxifenresist
tme
mr
cell
level
cm
tam
higher
differ
ms
mr
signific
ns
b
western
blot
analysi
pathway
cm
could
activ
pathway
tam
c
western
blot
analysi
pathway
cm
could
activ
pathway
tam
dephosphoryl
mr
obviou
ms
therefor
cm
promot
activ
pathway
p
p
macrophag
coincid
secret
result
chemotaxi
assay
confirm
chemotaxisinduc
effect
tam
toward
cell
stronger
macrophag
chemotaxisinduc
effect
mr
stronger
ms
bindarit
inhibitor
revers
enhanc
chemotaxi
abil
mr
figur
valid
phenomenon
vitro
analyz
tissu
sampl
patient
erposit
breast
cancer
immunohistochemistri
serial
patholog
section
show
high
express
paraneoplast
stroma
correl
infiltr
macrophag
r
p
figur
tabl
propos
tumor
cell
stimul
polar
macrophag
lead
increas
secret
high
concentr
turn
promot
aggreg
form
macrophag
determin
clinic
relev
endocrin
resist
vitro
find
select
patient
invas
erposit
breast
cancer
receiv
regular
endocrin
therapi
tumor
hospit
harbin
medic
univers
f
g
u
r
e
high
concentr
ccchemokin
ligand
recruit
monocyt
macrophag
facilit
endocrineresist
microenviron
breast
cancer
repres
photo
cell
recruit
condit
medium
cm
tam
tamoxifensensit
tumor
microenviron
tme
ms
tam
tamoxifenresist
tme
mr
mr
bindarit
chemotaxi
assay
quantit
result
show
chemotaxi
abil
tam
recruit
cell
enhanc
tam
endocrineresist
environ
stronger
chemotaxi
abil
bindarit
revers
enhanc
chemotaxi
abil
cm
mr
b
repres
imag
immunohistochem
stain
stain
serial
section
human
breast
cancer
sampl
relat
correl
analys
show
r
p
p
f
g
u
r
e
ccchemokin
ligand
express
stroma
correl
poor
recurrencefre
surviv
patient
hormon
receptorposit
breast
cancer
differ
pattern
immunohistochem
stain
stroma
breast
cancer
cell
b
kaplanmei
recurrencefre
surviv
curv
patient
hormon
receptorposit
breast
cancer
low
n
high
n
express
stroma
p
c
propos
model
tamsecret
activ
pathway
promot
malign
cycl
endocrin
resist
recruit
monocyt
tabl
result
show
pf
highexpress
group
significantli
shorter
lowexpress
group
p
prognost
valu
clinicopatholog
featur
assess
use
cox
hazard
regress
analysi
express
found
independ
risk
factor
diseasefre
surviv
df
hr
p
tabl
taken
togeth
result
indic
crucial
role
promot
endocrin
resist
breast
cancer
also
found
tam
promot
endocrin
resist
secret
activ
signal
pathway
therefor
play
import
role
malign
feedback
loop
addit
promot
aggreg
monocyt
macrophag
tme
transit
monocyt
tam
promot
format
endocrineresist
microenviron
analysi
tissu
sampl
patient
hormon
receptorposit
breast
cancer
confirm
correl
high
express
paraneoplast
stroma
infiltr
macrophag
moreov
patient
high
express
stroma
shorter
pf
endocrin
therapi
consist
find
previou
studi
patient
high
macrophag
infiltr
tend
develop
endocrin
resist
find
promot
format
tme
malign
cycl
cell
tme
may
partli
explain
patient
endocrin
resist
past
like
resist
new
endocrin
therapi
tumorassoci
macrophag
adjust
phenotyp
function
respons
local
cue
provid
tme
crosstalk
tam
cancer
cell
complex
involv
exosom
cytokin
metabolit
present
studi
focus
cytokin
secret
macrophag
ta
b
l
e
univari
multivari
analys
clinicopatholog
featur
associ
pf
patient
hormon
receptorposit
breast
cancer
examin
role
endocrin
resist
breast
cancer
cell
found
activ
pathway
classic
endocrin
resist
pathway
howev
direct
mechan
activ
pathway
determin
anoth
limit
present
studi
due
long
cultur
time
drugresist
cell
line
effect
endocrineresist
sensit
cell
line
macrophag
could
repeat
cell
compon
tme
complex
addit
tam
fibroblast
dendrit
cell
epitheli
cell
neutrophil
lymphocyt
also
tame
tumor
cell
promot
tumor
malign
environ
report
dendrit
cell
fibroblast
epitheli
cell
tame
cancer
cell
secret
studi
financi
support
nation
natur
scienc
author
declar
conflict
interest
articl
